Calin Radu

Clinical characteristics and treatment outcome in p16 negative anal cancer

Burgos, Catherine; Radu, Calin; Heyman, Sofia; Cavalli-Björkman, Nina et al.

Part of Acta Oncologica, p. 633-640, 2025

• DOI for Clinical characteristics and treatment outcome in p16 negative anal cancer
• Download full text (pdf) of Clinical characteristics and treatment outcome in p16 negative anal cancer

Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial

Nilsson, Per J.; Folkesson, Joakim; Marsk, Richard; Radu, Calin et al.

Part of BMJ Open, 2025

• DOI for Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial
• Download full text (pdf) of Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial

Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study

Than, Ngu Wah; Pritchard, D. Mark; Hughes, David M.; Yu, Kai Shing et al.

Part of Clinical and Translational Radiation Oncology, 2024

• DOI for Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study
• Download full text (pdf) of Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study

Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals

Heyman, Sofia; Perman, Mats; Radu, Calin

Part of Acta Oncologica, p. 118-124, 2024

• DOI for Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals
• Download full text (pdf) of Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals

Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

Nilsson, Martin P.; Undseth, Christine; Albertsson, Per; Eidem, Monika et al.

Part of Acta Oncologica, p. 897-906, 2023

• DOI for Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
• Download full text (pdf) of Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

Clinical characteristics and treatment outcome in p16 negative anal cancer

Burgos, Catherine; Radu, Calin; Heyman, Sofia; Cavalli-Björkman, Nina et al.

Part of Acta Oncologica, p. 633-640, 2025

• DOI for Clinical characteristics and treatment outcome in p16 negative anal cancer
• Download full text (pdf) of Clinical characteristics and treatment outcome in p16 negative anal cancer

Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial

Nilsson, Per J.; Folkesson, Joakim; Marsk, Richard; Radu, Calin et al.

Part of BMJ Open, 2025

• DOI for Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial
• Download full text (pdf) of Contact radiotherapy for rectal cancer (CORRECT): study protocol for a multicentre randomised phase II trial

Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study

Than, Ngu Wah; Pritchard, D. Mark; Hughes, David M.; Yu, Kai Shing et al.

Part of Clinical and Translational Radiation Oncology, 2024

• DOI for Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study
• Download full text (pdf) of Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre study

Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals

Heyman, Sofia; Perman, Mats; Radu, Calin

Part of Acta Oncologica, p. 118-124, 2024

• DOI for Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals
• Download full text (pdf) of Reduction of elective lymph node volume in radiotherapy of early anal squamous cell cancer: a comparative study between two Swedish university hospitals

Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

Nilsson, Martin P.; Undseth, Christine; Albertsson, Per; Eidem, Monika et al.

Part of Acta Oncologica, p. 897-906, 2023

• DOI for Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
• Download full text (pdf) of Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Dijkstra, Esmee A.; Hospers, Geke A. P.; Kranenbarg, Elma Meershoek-Klein; Fleer, Joke et al.

Part of Radiotherapy and Oncology, p. 69-76, 2022

• DOI for Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
• Download full text (pdf) of Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results

Johnsson, Anders; Norman, David; Angenete, Eva; Cavalli-Björkman, Nina et al.

Part of Acta Oncologica, p. 575-582, 2022

• DOI for Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results

Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

Backlund, Ellen; Yang, Muyi; Grozman, Vitali; Masucci, Giuseppe et al.

Part of Acta Oncologica, p. 869-873, 2022

• DOI for Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Erlandsson, Johan; Fuentes, Stina; Radu, Calin; Frödin, Jan-Erik et al.

Part of BJS Open, 2021

• DOI for Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
• Download full text (pdf) of Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Erlandsson, Johan; Holm, Torbjörn; Pettersson, David; Berglund, Åke et al.

Part of The Lancet Oncology, p. 336-346, 2017

• DOI for Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer

Leon, Otilia; Guren, Marianne G.; Radu, Calin; Gunnlaugsson, Adalsteinn et al.

Part of European Journal of Cancer, p. 2740-2746, 2015

• DOI for Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer

Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Radu, Calin; Norrlid, Ola; Braendengen, Morten; Hansson, Karl et al.

Part of Acta Oncologica, p. 528-537, 2013

• DOI for Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Brændengen, Morten; Hansson, Karl; Radu, Calin; Siegbahn, Albert et al.

Part of International Journal of Radiation Oncology, Biology, Physics, 2011

• DOI for Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Optimising Radiotherapy in Rectal Cancer Patients

Radu, Calin

2012

• Download full text (pdf) of Optimising Radiotherapy in Rectal Cancer Patients

Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Radu, Calin; Norrlid, Ola; Braendengen, Morten; Hansson, Karl et al.

Health-related quality-of-life during treatment in the Stockholm III Trial, evaluating different preoperative radiotherapy regimens for rectal cancer

Radu, Calin; Johansson, Birgitta; Pettersson, David; Martling, Anna et al.

Is it safe to exercise during oncological treatment?: A study of adverse events during exercise - data from the Phys-Can study

Henriksson, Anna; Johansson, Birgitta; Radu, Calin; Igelström, Helena et al.